SCHEMBL30890722

SCHEMBL30890722

CCCCOC(=O)N1C[C@@]2(C[C@H]1C(N)=O)Oc1cc(F)cc(Br)c1NC2=O

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890406 0.88 MEN1 (0.31) MEN1KMT2A
SCHEMBL30890776 0.88 MEN1 (0.31) MEN1KMT2A
SCHEMBL30890432 0.84 — —
SCHEMBL30890780 0.83 MAOB (0.34) MEN1KMT2A
SCHEMBL30890571 0.81 MAPT (0.34) MEN1KMT2A
SCHEMBL30890412 0.79 HSD17B10 (0.36) MEN1KMT2A
SCHEMBL30890536 0.79 MAOB (0.30) —
SCHEMBL30890474 0.78 TSHR (0.32) MEN1KMT2A
SCHEMBL30890648 0.76 — —
SCHEMBL30890580 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback